Abstract
Purpose :
To describe the incidence of secondary glaucoma and/or ocular hypertension in patients with herpetic uveitis, as well as its therapeutic management in third level ophthalmologic center in Mexico.
Methods :
A period of five years was analyzed through a database of patients that were seen in our uvea service from January 2010 to December 2015, with the diagnosis of herpetic uveitis (herpes simplex or varicela-zoster). Patients with 6 months follow-up of were included. Patients who did not follow up or who stopped medical treatment were excluded.
Results :
We studied 264 patients with herpetic uveitis diagnosis and its association with secondary glaucoma or ocular hypertension; Only 14% (37 patients) of the total of patients developed secondary glaucoma and 18% (47 patients) developed ocular hypertension. Of the 14% of patients with uveitis glaucoma, 80% required treatment with an Ahmed valve implant (29 patients), versus 4% (9 patients) only medical treatment (hypotensive monotherapy); 47 patients (18%) who o whom developed ocular hypertension were treated with beta-blocker monotherapy. Regarding intraocular pressure, in the secondary glaucoma group the mean pre-treatment intraocular pressure was 31mmHg, the intraocular pressure after treatment was 12mmHg; in the ocular hypertension group the pre-treatment intraocular pressure was 24 mmHg; The intraocular pressure after treatment was 11 mmHg.
Conclusions :
Herpetic uveitis is one of the most common pathologies in Ophthalmology and Ophthalmologic Emergency service therefore the importance of an early diagnosis that could avoid complications such as uveitis and/or ocular hypertension.
This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.